Genentech, Roche Holdings Ltd. deal

The companies revised provisions of their 1995 agreement involving their division of product development costs. The original agreement called for Roche to opt-in to projects at the end of Phase II

Read the full 314 word article

How to gain access

Continue reading with a
two-week free trial.